Table 1.
Male gender (%) | 68 (69.4) |
Age (years) | 35 [30-38] |
CD4+ count (cell/mm3) | 321 [212-491] |
HIV-1 viral load (log10IU/mL) | 4.28 [1.6-4.8] |
Naïve ART patients (%) | 62 (63,2) |
Time in treatment (months) | 25.1 [14.2-48.1] |
Risk factor (%) | |
Heterosexual | 41 (41.8) |
Bisexual | 42 (42,8) |
Injecting drug users | 7 (7.1) |
Others | 8 (8.1) |
Geographical Region (%) | |
Central-South America | 47 (47.9) |
Western Europe | 14 (14,3) |
Sub-Saharan Africa | 19 (19.4) |
Northern Africa | 5 (5.1) |
Eastern Europe | 10 (10.2) |
North America | 1 (1) |
Asia | 1 (1) |
Not determined | 1 (1) |